Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies
about
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infectionsChikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoesDevelopment of a highly protective combination monoclonal antibody therapy against Chikungunya virusA synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopesMonoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in miceAntibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing)Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanismDevelopment of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strainsLocking and Blocking the Viral Landscape of an Alphavirus with Neutralizing AntibodiesIsolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivoRecombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virusThe first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activityTreatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection.Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus.A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro.A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus.Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection.A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcγ receptors to define the role of effector functions in protection against HIV.Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encepha
P2860
Q24289014-F47146AA-E2DF-4108-B5C9-647981F2D04AQ24701786-545C53B1-82D1-491C-B731-D3F885FF74E6Q27335008-1368F65D-F351-4DB0-9197-523015405DA7Q27486187-05FB4A9B-C8E9-417F-909A-1EAA275C2953Q27486805-3BAB4856-F1E5-48ED-B873-A73D83C00673Q27486833-7C327F20-367A-4381-90C0-D4506477855BQ27489809-BB297D51-CA3D-4072-88D2-3126DD95CAE8Q27490432-3D6C7FFB-8C74-4925-BCA7-BA94F6B6220CQ27684308-18CF41B0-1E58-4DED-AC57-349E859509EFQ28483998-67FBB21B-517D-41B9-BED7-9E375F430B2CQ33800760-3937718B-ECDC-44F2-95C3-5DE13D5793B3Q33803787-9A7EF6F0-821E-45C9-925C-6CFE94956B24Q33991546-B227F323-0191-4D60-B435-0D00244AFAD6Q34991116-C7972D1E-CDB6-426B-BB0C-1F73E1EA2098Q35851163-666122C6-8847-4905-8D59-FA12B991D7C2Q35886309-15E7D0A9-187B-4C98-B219-BB1C8C3FEFB5Q36685338-42BCB061-AF85-409D-A27D-1DA93D64FD02Q36698867-5ECF2120-F399-429D-B534-FD64ECDD984CQ38631835-09655A60-592C-4046-82DD-522BF88C0780Q39789318-6AE8635A-13A1-41EB-A92F-21FD2696E18DQ55400521-8789E63D-8528-4184-9C51-90B94EABE45B
P2860
Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies
description
1985 nî lūn-bûn
@nan
1985 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Role of complement and the Fc ...... specific monoclonal antibodies
@ast
Role of complement and the Fc ...... specific monoclonal antibodies
@en
Role of complement and the Fc ...... specific monoclonal antibodies
@nl
type
label
Role of complement and the Fc ...... specific monoclonal antibodies
@ast
Role of complement and the Fc ...... specific monoclonal antibodies
@en
Role of complement and the Fc ...... specific monoclonal antibodies
@nl
prefLabel
Role of complement and the Fc ...... specific monoclonal antibodies
@ast
Role of complement and the Fc ...... specific monoclonal antibodies
@en
Role of complement and the Fc ...... specific monoclonal antibodies
@nl
P2093
P2860
P1433
P1476
Role of complement and the Fc ...... specific monoclonal antibodies
@en
P2093
P2860
P304
P577
1985-09-01T00:00:00Z